title: [Is the intestinal transplant a reality?].
abstract: Small bowel transplantation trials before cyclosporine was unavailable because of rejection, graft-versus-host disease and technical problems. With the discovery of cyclosporine, and another immunosuppressors like prednisone, antithymocyte globulin, azathioprine, OKT3 and the recent rapamycin, mycophenolate mofetil, deoxyspergualin, FK506, mizoribine and brequinar sodium, the prognosis for small bowel transplanted patients is better than before.
authors.affiliation: Servicio de Cirugia General, Hospital General Dr. Manuel Gea González, México, D.F.
authors.forename: M
authors.initials: M
authors.lastname: Erbessd López
authors.forename: A J
authors.initials: AJ
authors.lastname: Athié
mesh_terms: D006084:Graft Rejection / Q000517:prevention & control; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007422:Intestines / Q000637:transplantation*; D008991:Monitoring, Physiologic
vernacular_title: Es una realidad el trasplante intestinal?